カテゴリー： QYResearch, 世界

世界の膿痂疹薬市場 2019年

【英語タイトル】Global Impetigo Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X09571）・商品コード：DATA909X09571
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、膿痂疹薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、FMX-102、LTX-109、ムピロシン、オゼノキサシン、その他に、用途別には、クリニック、病院、その他にセグメント区分し、膿痂疹薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・膿痂疹薬の世界市場概要
・膿痂疹薬の製造コスト構成分析
・膿痂疹薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・膿痂疹薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・膿痂疹薬のセグメント分析（種類別）
（FMX-102、LTX-109、ムピロシン、オゼノキサシン、その他）
・膿痂疹薬のセグメント分析（用途別）
（クリニック、病院、その他）
・膿痂疹薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Destiny Pharma Ltd、Foamix Pharmaceuticals Ltd、Fujifilm Holdings Corporation、Laboratories Ojer Pharma SL、Lytix Biopharma AS、）
・膿痂疹薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Impetigo Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Impetigo Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Impetigo Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Impetigo Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Impetigo Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Destiny Pharma Ltd
Foamix Pharmaceuticals Ltd
Fujifilm Holdings Corporation
Laboratories Ojer Pharma SL
Lytix Biopharma AS
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
FMX-102
LTX-109
Mupirocin
Ozenoxacin
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Impetigo Drug
1.1 Definition of Impetigo Drug
1.2 Impetigo Drug Segment by Type
1.2.1 Global Impetigo Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 FMX-102
1.2.3 LTX-109
1.2.4 Mupirocin
1.2.5 Ozenoxacin
1.2.6 Others
1.3 Impetigo Drug Segment by Applications
1.3.1 Global Impetigo Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Impetigo Drug Overall Market
1.4.1 Global Impetigo Drug Revenue (2014-2025)
1.4.2 Global Impetigo Drug Production (2014-2025)
1.4.3 North America Impetigo Drug Status and Prospect (2014-2025)
1.4.4 Europe Impetigo Drug Status and Prospect (2014-2025)
1.4.5 China Impetigo Drug Status and Prospect (2014-2025)
1.4.6 Japan Impetigo Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Impetigo Drug Status and Prospect (2014-2025)
1.4.8 India Impetigo Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Impetigo Drug
2.3 Manufacturing Process Analysis of Impetigo Drug
2.4 Industry Chain Structure of Impetigo Drug

3 Development and Manufacturing Plants Analysis of Impetigo Drug
3.1 Capacity and Commercial Production Date
3.2 Global Impetigo Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Impetigo Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Impetigo Drug Production and Capacity Analysis
4.2 Impetigo Drug Revenue Analysis
4.3 Impetigo Drug Price Analysis
4.4 Market Concentration Degree

5 Impetigo Drug Regional Market Analysis
5.1 Impetigo Drug Production by Regions
5.1.1 Global Impetigo Drug Production by Regions
5.1.2 Global Impetigo Drug Revenue by Regions
5.2 Impetigo Drug Consumption by Regions
5.3 North America Impetigo Drug Market Analysis
5.3.1 North America Impetigo Drug Production
5.3.2 North America Impetigo Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Impetigo Drug Import and Export
5.4 Europe Impetigo Drug Market Analysis
5.4.1 Europe Impetigo Drug Production
5.4.2 Europe Impetigo Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Impetigo Drug Import and Export
5.5 China Impetigo Drug Market Analysis
5.5.1 China Impetigo Drug Production
5.5.2 China Impetigo Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Impetigo Drug Import and Export
5.6 Japan Impetigo Drug Market Analysis
5.6.1 Japan Impetigo Drug Production
5.6.2 Japan Impetigo Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Impetigo Drug Import and Export
5.7 Southeast Asia Impetigo Drug Market Analysis
5.7.1 Southeast Asia Impetigo Drug Production
5.7.2 Southeast Asia Impetigo Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Impetigo Drug Import and Export
5.8 India Impetigo Drug Market Analysis
5.8.1 India Impetigo Drug Production
5.8.2 India Impetigo Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Impetigo Drug Import and Export

6 Impetigo Drug Segment Market Analysis (by Type)
6.1 Global Impetigo Drug Production by Type
6.2 Global Impetigo Drug Revenue by Type
6.3 Impetigo Drug Price by Type

7 Impetigo Drug Segment Market Analysis (by Application)
7.1 Global Impetigo Drug Consumption by Application
7.2 Global Impetigo Drug Consumption Market Share by Application (2014-2019)

8 Impetigo Drug Major Manufacturers Analysis
8.1 Destiny Pharma Ltd
8.1.1 Destiny Pharma Ltd Impetigo Drug Production Sites and Area Served
8.1.2 Destiny Pharma Ltd Product Introduction, Application and Specification
8.1.3 Destiny Pharma Ltd Impetigo Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Foamix Pharmaceuticals Ltd
8.2.1 Foamix Pharmaceuticals Ltd Impetigo Drug Production Sites and Area Served
8.2.2 Foamix Pharmaceuticals Ltd Product Introduction, Application and Specification
8.2.3 Foamix Pharmaceuticals Ltd Impetigo Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Fujifilm Holdings Corporation
8.3.1 Fujifilm Holdings Corporation Impetigo Drug Production Sites and Area Served
8.3.2 Fujifilm Holdings Corporation Product Introduction, Application and Specification
8.3.3 Fujifilm Holdings Corporation Impetigo Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Laboratories Ojer Pharma SL
8.4.1 Laboratories Ojer Pharma SL Impetigo Drug Production Sites and Area Served
8.4.2 Laboratories Ojer Pharma SL Product Introduction, Application and Specification
8.4.3 Laboratories Ojer Pharma SL Impetigo Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Lytix Biopharma AS
8.5.1 Lytix Biopharma AS Impetigo Drug Production Sites and Area Served
8.5.2 Lytix Biopharma AS Product Introduction, Application and Specification
8.5.3 Lytix Biopharma AS Impetigo Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Impetigo Drug Market
9.1 Global Impetigo Drug Market Trend Analysis
9.1.1 Global Impetigo Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Impetigo Drug Regional Market Trend
9.2.1 North America Impetigo Drug Forecast 2019-2025
9.2.2 Europe Impetigo Drug Forecast 2019-2025
9.2.3 China Impetigo Drug Forecast 2019-2025
9.2.4 Japan Impetigo Drug Forecast 2019-2025
9.2.5 Southeast Asia Impetigo Drug Forecast 2019-2025
9.2.6 India Impetigo Drug Forecast 2019-2025
9.3 Impetigo Drug Market Trend (Product Type)
9.4 Impetigo Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Impetigo Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Impetigo Drug
Table Global Impetigo Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Impetigo Drug Production Market Share by Types in 2018
Figure FMX-102 Product Picture
Figure LTX-109 Product Picture
Figure Mupirocin Product Picture
Figure Ozenoxacin Product Picture
Figure Others Product Picture
Table Global Impetigo Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Impetigo Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Impetigo Drug Revenue (Million USD) (2014-2025)
Figure Global Impetigo Drug Production (K Pcs) (2014-2025)
Figure North America Impetigo Drug Market Size (Million USD) (2014-2025)
Figure Europe Impetigo Drug Market Size (Million USD) (2014-2025)
Figure China Impetigo Drug Market Size (Million USD) (2014-2025)
Figure Japan Impetigo Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Impetigo Drug Market Size (Million USD) (2014-2025)
Figure India Impetigo Drug Market Size (Million USD) (2014-2025)
Table Impetigo Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Impetigo Drug in 2018
Figure Manufacturing Process Analysis of Impetigo Drug
Figure Industry Chain Structure of Impetigo Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Impetigo Drug Manufacturing Plants Distribution
Table Impetigo Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Impetigo Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Impetigo Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Impetigo Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Impetigo Drug Production Share by Manufacturers in 2018
Table Impetigo Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Impetigo Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Impetigo Drug Revenue Share by Manufacturers in 2018
Table Impetigo Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Impetigo Drug Production by Regions 2014-2019 (K Pcs)
Table Global Impetigo Drug Production Market Share by Regions 2014-2019
Figure Global Impetigo Drug Production Market Share by Regions in 2018
Table Global Impetigo Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Impetigo Drug Revenue Market Share by Regions 2014-2019
Figure Global Impetigo Drug Revenue Market Share by Regions in 2018
Table Global Impetigo Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Impetigo Drug Consumption Market Share by Regions 2014-2019
Figure North America Impetigo Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Impetigo Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Impetigo Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Impetigo Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Impetigo Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Impetigo Drug Production, Consumption Import and Export (K Pcs)
Figure China Impetigo Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Impetigo Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Impetigo Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Impetigo Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Impetigo Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Impetigo Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Impetigo Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Impetigo Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Impetigo Drug Production, Consumption Import and Export (K Pcs)
Figure India Impetigo Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Impetigo Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Impetigo Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Impetigo Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Impetigo Drug Market Share by Application (2014-2019)
Table Destiny Pharma Ltd Impetigo Drug Production Sites and Area Served
Table Destiny Pharma Ltd Impetigo Drug Product Introduction, Application and Specification
Table Destiny Pharma Ltd Impetigo Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Destiny Pharma Ltd Impetigo Drug Production Growth Rate (2014-2019)
Table Destiny Pharma Ltd Impetigo Drug Production Market Share (2014-2019)
Figure Destiny Pharma Ltd Impetigo Drug Revenue Market Share (2014-2019)
Table Destiny Pharma Ltd Impetigo Drug Main Business and Markets Served
Table Foamix Pharmaceuticals Ltd Impetigo Drug Production Sites and Area Served
Table Foamix Pharmaceuticals Ltd Impetigo Drug Product Introduction, Application and Specification
Table Foamix Pharmaceuticals Ltd Impetigo Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Foamix Pharmaceuticals Ltd Impetigo Drug Production Growth Rate (2014-2019)
Table Foamix Pharmaceuticals Ltd Impetigo Drug Production Market Share (2014-2019)
Figure Foamix Pharmaceuticals Ltd Impetigo Drug Revenue Market Share (2014-2019)
Table Foamix Pharmaceuticals Ltd Impetigo Drug Main Business and Markets Served
Table Fujifilm Holdings Corporation Impetigo Drug Production Sites and Area Served
Table Fujifilm Holdings Corporation Impetigo Drug Product Introduction, Application and Specification
Table Fujifilm Holdings Corporation Impetigo Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Fujifilm Holdings Corporation Impetigo Drug Production Growth Rate (2014-2019)
Table Fujifilm Holdings Corporation Impetigo Drug Production Market Share (2014-2019)
Figure Fujifilm Holdings Corporation Impetigo Drug Revenue Market Share (2014-2019)
Table Fujifilm Holdings Corporation Impetigo Drug Main Business and Markets Served
Table Laboratories Ojer Pharma SL Impetigo Drug Production Sites and Area Served
Table Laboratories Ojer Pharma SL Impetigo Drug Product Introduction, Application and Specification
Table Laboratories Ojer Pharma SL Impetigo Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Laboratories Ojer Pharma SL Impetigo Drug Production Growth Rate (2014-2019)
Table Laboratories Ojer Pharma SL Impetigo Drug Production Market Share (2014-2019)
Figure Laboratories Ojer Pharma SL Impetigo Drug Revenue Market Share (2014-2019)
Table Laboratories Ojer Pharma SL Impetigo Drug Main Business and Markets Served
Table Lytix Biopharma AS Impetigo Drug Production Sites and Area Served
Table Lytix Biopharma AS Impetigo Drug Product Introduction, Application and Specification
Table Lytix Biopharma AS Impetigo Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Lytix Biopharma AS Impetigo Drug Production Growth Rate (2014-2019)
Table Lytix Biopharma AS Impetigo Drug Production Market Share (2014-2019)
Figure Lytix Biopharma AS Impetigo Drug Revenue Market Share (2014-2019)
Table Lytix Biopharma AS Impetigo Drug Main Business and Markets Served
Figure Global Impetigo Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Impetigo Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Impetigo Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Impetigo Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Impetigo Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Impetigo Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Impetigo Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Impetigo Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Impetigo Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Impetigo Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Impetigo Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Impetigo Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Impetigo Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Impetigo Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Impetigo Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Impetigo Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Impetigo Drug by Application (2019-2025)
Table Impetigo Drug Distributors List
Table Impetigo Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Destiny Pharma Ltd、Foamix Pharmaceuticals Ltd、Fujifilm Holdings Corporation、Laboratories Ojer Pharma SL、Lytix Biopharma AS、

★調査レポート[世界の膿痂疹薬市場 2019年] (コード：DATA909X09571)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の膿痂疹薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 膿痂疹治療の世界市場：規模・現状・予測2019-2025
    DATA909X18560 / QYResearch / 2019年11月25日 / ※当調査レポートでは、膿痂疹治療の世界市場について調査・分析し、膿痂疹治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（セファロスポリン、フシダン、リンコサミド抗生物質、ペニシリン、ペニシリン様抗生物質、プロイロムチリン、プソドモン酸A、キノロン、スルホンアミドおよび葉酸阻害剤、テトラサイクリン）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の膿痂疹治療市場動向 ・主要企業別マーケットシェア ・膿痂疹治療の種類別市場規模2014-2019 （セファロスポリン、フシダン、リンコサミド抗生物質、ペニシリン、ペニシリン様抗生物質、プロイロムチリン、プソドモン酸A、キノロン、スルホンアミドおよび葉酸阻害剤、テトラサイクリン） ・膿痂疹治療の用途別市場規模2014-2019 （病院、診療所、その他） ・膿痂疹治療の北米市場：主要企業・種類別/用途別市場規模 ・膿痂疹治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Impetigo Treatment is typically treated with an antibiotic ointment or cream that apply directly to the sores.In 2018, the global Impetigo Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Impetigo Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Impetigo Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study GlaxoSmithKline plc...
  • 世界の二次性副甲状腺機能亢進薬市場 2019年
    DATA909X14807 / QYResearch / 2019年11月20日 / ※本調査レポートは、二次性副甲状腺機能亢進薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エボカルセト、LNP-1892、AJT-240、シナカルセト塩酸塩、CTA-091、その他に、用途別には、病院、診療所、その他にセグメント区分し、二次性副甲状腺機能亢進薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・二次性副甲状腺機能亢進薬の世界市場概要 ・二次性副甲状腺機能亢進薬の製造コスト構成分析 ・二次性副甲状腺機能亢進薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・二次性副甲状腺機能亢進薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・二次性副甲状腺機能亢進薬のセグメント分析（種類別） （エボカルセト、LNP-1892、AJT-240、シナカルセト塩酸塩、CTA-091、その他）...The global Secondary Hyperparathyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Secondary Hyperparathyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Secondary Hyperparathyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Secondary Hyperparathyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のパーキンソン病薬市場 2019年
    DATA909X12634 / QYResearch / 2019年11月20日 / ※本調査レポートは、パーキンソン病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、シネメット-CR、トラスター、マドパル、COMT阻害剤、その他に、用途別には、40歳未満、40-65歳、65歳以上にセグメント区分し、パーキンソン病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・パーキンソン病薬の世界市場概要 ・パーキンソン病薬の製造コスト構成分析 ・パーキンソン病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・パーキンソン病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・パーキンソン病薬のセグメント分析（種類別） （シネメット-CR、トラスター、マドパル、COMT阻害剤、その他）...The global Parkinson's Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Parkinson's Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson's Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Parkinson's Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のクローン病薬市場 2019年
    DATA909X06111 / QYResearch / 2019年11月15日 / ※本調査レポートは、クローン病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節薬、抗生物質に、用途別には、寛解の達成（症状の欠如）、寛解の維持（再燃の予防）、小児クローン病にセグメント区分し、クローン病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・クローン病薬の世界市場概要 ・クローン病薬の製造コスト構成分析 ・クローン病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・クローン病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・クローン病薬のセグメント分析（種類別） （アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節薬、抗生物質）...The global Crohn’s Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Crohn’s Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Crohn’s Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Crohn’s Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の視神経症薬市場 2019年
    DATA909X12314 / QYResearch / 2019年11月20日 / ※本調査レポートは、視神経症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BA-240、IWP-953、LM-22A4、その他に、用途別には、クリニック、病院、在宅ケアにセグメント区分し、視神経症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・視神経症薬の世界市場概要 ・視神経症薬の製造コスト構成分析 ・視神経症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・視神経症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・視神経症薬のセグメント分析（種類別） （BA-240、IWP-953、LM-22A4、その他）...The global Optic Neuropathy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Optic Neuropathy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Optic Neuropathy Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Optic Neuropathy Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の腎盂腎炎炎薬市場 2019年
    DATA909X13967 / QYResearch / 2019年11月20日 / ※本調査レポートは、腎盂腎炎炎薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、フィナフロキサシン、ホスホマイシントロメタミン、ナクバクタム、硫酸プラゾマイシン、その他に、用途別には、病院、診療所、その他にセグメント区分し、腎盂腎炎炎薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・腎盂腎炎炎薬の世界市場概要 ・腎盂腎炎炎薬の製造コスト構成分析 ・腎盂腎炎炎薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・腎盂腎炎炎薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・腎盂腎炎炎薬のセグメント分析（種類別） （フィナフロキサシン、ホスホマイシントロメタミン、ナクバクタム、硫酸プラゾマイシン、その他）...The global Pyelonephritis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pyelonephritis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pyelonephritis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pyelonephritis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Pyelonephritis Drug manufacturing...
  • 世界の動脈血栓症薬市場 2019年
    DATA909X03729 / QYResearch / 2019年11月15日 / ※本調査レポートは、動脈血栓症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AS-1468240、ASP-6537、BAY-1213790、BMS-65445、その他に、用途別には、クリニック、病院、その他にセグメント区分し、動脈血栓症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・動脈血栓症薬の世界市場概要 ・動脈血栓症薬の製造コスト構成分析 ・動脈血栓症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・動脈血栓症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・動脈血栓症薬のセグメント分析（種類別） （AS-1468240、ASP-6537、BAY-1213790、BMS-65445、その他）...The global Arterial Thrombosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Arterial Thrombosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Arterial Thrombosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Arterial Thrombosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の平滑筋肉腫薬市場 2019年
    DATA909X10490 / QYResearch / 2019年11月20日 / ※本調査レポートは、平滑筋肉腫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AL-3818、BGB-290、C-21、その他に、用途別には、クリニック、病院、その他にセグメント区分し、平滑筋肉腫薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・平滑筋肉腫薬の世界市場概要 ・平滑筋肉腫薬の製造コスト構成分析 ・平滑筋肉腫薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・平滑筋肉腫薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・平滑筋肉腫薬のセグメント分析（種類別） （AL-3818、BGB-290、C-21、その他）...The global Leiomyosarcoma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Leiomyosarcoma Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Leiomyosarcoma Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Leiomyosarcoma Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Leiomyosarcoma Drug manufacturing...

    • ◆H&Iグローバルリサーチのお客様（例）◆